STAAR Surgical Company share price logo

STAAR Surgical Company

NASDAQ: STAA

Small Cap

$28.18

+0.35

(+1.26%)

as on

STAAR Surgical Company Stock Performance

as on May 13, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $27.38
    $28.56
    downward going graph

    2.84%

    Downside

    1.35%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $15.59
    $30.81
    downward going graph

    44.69%

    Downside

    9.33%

    Upside

    downward going graph

STAAR Surgical Company share price movements today

Previous Close
$27.83
Open
$27.84
Volume
638.6K
Day's Low - High
$27.38 - $28.56
52 Week Low - High
$15.59 - $30.81

STAAR Surgical Company Historical Returns

1 Month Return
+ 5.26 %
3 Month Return
+ 68.77 %
1 Year Return
+ 37.3 %
3 Year Return
-55.54 %
5 Year Return
-74.88 %

STAAR Surgical Company Stock Fundamentals & Key Indicators

Check STAAR Surgical Company market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.4B

EPS (TTM)

0.5533

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.10%

PE Ratio (TTM)

0

PEG Ratio

0.7622

EBITDA

-37.4M

Revenue (TTM)

239.4M

Profit Margin

-33.60%

Return On Equity TTM

-21.70%

STAAR Surgical Company vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of STAAR Surgical Company with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.4B-74.88%NA-33.60%
BUY$159.4B55.23%54.6228.15%
BUY$30.0B3.35%19.9227.44%
BUY$30.5B-6.41%37.467.70%
BUY$39.4B-40.76%24.985.12%

Stock Returns calculator for STAAR Surgical Company Stock including INR - Dollar returns

The STAAR Surgical Company stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

STAAR Surgical Company investment value today

Current value as on today

₹1,56,602

Returns

₹56,602

(+56.6%)

Returns from STAAR Surgical Company Stock

₹39,023 (+39.02%)

Dollar Impact

₹17,579 (+17.58%)

Analyst Recommendation on STAAR Surgical Company Stock

Based on 19 analysts

BUY

63.16%

Buy

36.84%

Hold

0.00%

Sell

Based on 19 analysts, 63.16% of analysts recommend a 'BUY' rating for STAAR Surgical Company. Average target price of $21.11

STAAR Surgical Company Share Price Target

Get share price movements and forecasts by analysts on STAAR Surgical Company.

What analysts predicted

-33.49%DOWNSIDE

Target Price

$21.11

Current Price

$28.18

Analyzed by

19 Analysts

Target

$21.11

STAAR Surgical Company target price $21.11, a slight downside of -33.49% compared to current price of $28.18. According to 19 analysts rating.

Indian Investors' Interest in STAAR Surgical Company Stock

Search interest for STAAR Surgical Company Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-54% versus previous 30 day period

STAAR Surgical Company Quarterly Profit & Loss

All numbers in Millions USD

Jan 2024
Mar 2024
Apr 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
76
77
77
99
88
48
42
44
94
57
Gross Profit
-
61
-
78
68
31
28
32
77
42
Operating Income
-
-2
-
11
5
-27
-57
-29
18
-10
EBITDA
-
-1
-
13
7
-25
-32
-22
26
-8
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
1
-
1
1
2
2
1
2
2
Income Before Tax
-
-2
-
10
13
-30
-54
-25
18
-20
Income Tax Expense
-
1
-
2
3
3
0
-9
9
-2
Net Income
7
-3
-3
7
9
-34
-54
-16
8
-18
Net Profit Margin
10.17%
-4.32%
-4.32%
7.45%
11.27%
-69.92%
-127.29%
-37.93%
9.38%
-31.68%

STAAR Surgical Company Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Jan 2021
Dec 2021
Jan 2022
Dec 2022
Jan 2023
Dec 2023
Jan 2024
Dec 2024
Dec 2025
Total Revenue
163
163
230
230
284
284
322
322
313
239
Gross Profit
118
-
178
-
223
-
252
-
239
176
Operating Income
6
-
33
-
43
-
28
-
-12
-45
EBITDA
9
-
36
-
48
-
33
-
-5
-37
Interest Expense
2
-
0
-
2
-
-
-
-
-
Depreciation
3
-
3
-
4
-
5
-
6
8
Income Before Tax
8
-
31
-
45
-
33
-
-9
-82
Income Tax Expense
2
-
3
-
5
-
12
-
11
-1
Net Income
5
5
27
27
39
39
21
21
-20
-80
Net Profit Margin
3.62%
3.62%
11.94%
11.94%
13.95%
13.95%
6.62%
6.62%
-6.44%
-33.60%

STAAR Surgical Company Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
7
-3
7
9
-34
-54
-16
8
0
Operating Cash Flow
31
21
-10
3
0
-5
-27
2
0
Investing Cash Flow
22
16
-20
-35
-19
35
25
5
0
Financing Cash Flow
0
4
0
1
0
0
-4
0
0
Change in Cash
55
40
-31
-28
-19
28
-5
9
0

STAAR Surgical Company Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-2
4
14
5
27
39
21
-20
-80
Operating Cash Flow
2
12
25
20
43
35
14
15
-34
Investing Cash Flow
-1
-2
-10
-8
-13
-156
74
-59
46
Financing Cash Flow
2
74
0
19
17
8
7
5
-4
Change in Cash
4
85
15
32
47
-113
96
-38
8

Global Institutional Holdings in STAAR Surgical Company

Funds
Holdings
BlackRock Inc
14.78%
Magnetar Financial LLC
4.97%
Bank of America Corp
2.33%
Palo Alto Investors, LLC
1.6%
Cnh Partners, LLC
1.84%

Insights on STAAR Surgical Company

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, STAA stock has moved up by 72.9%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, STAA has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, STAAR Surgical Co has experienced a drawdown of -55.5%, however Intuitive Surgical, Inc. resisted the overall trend and outperformed by 12.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 8.88M → -18.30M (in $), with an average decrease of 306.1% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 94.73M → 57.80M (in $), with an average decrease of 39.0% per quarter

About STAAR Surgical Company

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
OrganisationSTAAR Surgical Company
Headquarters25510 Commercentre Drive, Lake Forest, CA, United States, 92630
IndustryMedical Instruments & Supplies
CEOMr. Warren Foust
E-voting on sharesClick here to vote

Key Management of STAAR Surgical Company

Name

Title

Mr. Warren Foust

Interim Co-CEO, President & COO

Dr. Magda Michna Ph.D.

Chief Development Officer

Ms. Deborah J. Andrews

Interim Co-CEO & CFO

Ms. Connie Johnson

Director of Investor Relations

Ms. Nancy Sabin

Chief Marketing Officer

Dr. Scott D. Barnes M.D.

Chief Medical Officer

FAQs

What is STAAR Surgical Company share price today?

STAAR Surgical Company share price today is $28.18 as on at the close of the market. STAAR Surgical Company share today touched a day high of $28.56 and a low of $27.38.

What is the 52 week high and 52 week low for STAAR Surgical Company share?

STAAR Surgical Company share touched a 52 week high of $30.81 on and a 52 week low of $15.59 on . STAAR Surgical Company stock price today i.e. is closed at $28.18,which is 8.54% down from its 52 week high and 80.81% up from its 52 week low.

What is STAAR Surgical Company's market capitalisation today?

STAAR Surgical Company market capitalisation is $0.00T as on .

How to invest in STAAR Surgical Company Stock (STAA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for STAAR Surgical Company on INDmoney app. Click on Buy button. You can invest as low as $1.5 in STAAR Surgical Company Shares that will get you 0.0532 shares as per STAAR Surgical Company share price of $28.18 per share as on May 13, 2026 at 8:45 am IST.

What is the minimum amount required to buy STAAR Surgical Company Stock (STAA) from India?

Indian investors can start investing in STAAR Surgical Company (STAA) shares with as little as ₹95.618 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in STAAR Surgical Company stock (as per the Rupee-Dollar exchange rate as on ). Based on STAAR Surgical Company share’s latest price of $28.18 as on May 13, 2026 at 8:45 am IST, you will get 0.3549 shares of STAAR Surgical Company. Learn more about fractional shares .

What are the returns that STAAR Surgical Company has given to Indian investors in the last 5 years?

STAAR Surgical Company stock has given -74.88% share price returns and 29.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?